NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 142,100 shares, a decrease of 25.0% from the March 15th total of 189,400 shares. Approximately 20.4% of the company’s stock are sold short. Based on an average daily trading volume, of 2,960,000 shares, the days-to-cover ratio is currently 0.0 days.
Institutional Inflows and Outflows
An institutional investor recently raised its position in NewGenIvf Group stock. XTX Topco Ltd grew its stake in NewGenIvf Group Limited (NASDAQ:NIVF – Free Report) by 400.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 73,801 shares of the company’s stock after buying an additional 59,059 shares during the quarter. XTX Topco Ltd owned 0.73% of NewGenIvf Group worth $30,000 as of its most recent filing with the SEC. 66.24% of the stock is owned by institutional investors and hedge funds.
NewGenIvf Group Price Performance
Shares of NIVF stock opened at $0.28 on Monday. The firm has a 50 day moving average of $1.18 and a two-hundred day moving average of $7.09. NewGenIvf Group has a 52 week low of $0.26 and a 52 week high of $65.60.
About NewGenIvf Group
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.
Further Reading
- Five stocks we like better than NewGenIvf Group
- How to Profit From Growth Investing
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- A Deeper Look at Bid-Ask Spreads
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- Conference Calls and Individual Investors
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.